Medrx Co., Ltd.

36
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921220004
JPY
110.00
7 (6.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Medrx Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-925.00
-802.00
-930.00
-1,109.00
-1,058.00
-1,106.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
26.00
-91.00
-29.00
-10.00
75.00
70.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-888.00
-803.00
-913.00
-1,073.00
-923.00
-985.00
Cash Flow from Investing Activities
-82.00
-3.00
0.00
-1.00
-2.00
-5.00
Cash Flow from Financing Activities
745.00
1,066.00
1,639.00
356.00
815.00
1,393.00
Net Cash Inflow / Outflow
-222.00
256.00
726.00
-709.00
-108.00
401.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
2.00
-3.00
1.00
9.00
1.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medrx Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-925.054
-1017.729
92.00
9.11%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
26.277
12.84
14.00
104.65%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-888.109
-996.966
108.00
10.92%
Cash Flow from Investing Activities
-82.752
67.178
-149.00
-223.18%
Cash Flow from Financing Activities
745.093
667.263
78.00
11.66%
Net Cash Inflow / Outflow
-222.969
-262.619
40.00
15.10%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
2.799
-0.094
2.00
3077.66%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -10.54% vs 12.08% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-888.11
-803.40
-10.54%